HEADER APOPTOSIS/INHIBITOR 27-OCT-17 6BG0 TITLE CASPASE-3 MUTANT - D9A,D28A,S150D CAVEAT 6BG0 THE DISTANCE BETWEEN THE S OF CYS 163 AND THE C-TERMINUS OF CAVEAT 2 6BG0 THE INHIBITOR IS TOO LONG FOR COVALENT BOND COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-3; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CASP-3,APOPAIN,CYSTEINE PROTEASE CPP32,CPP-32,PROTEIN YAMA, COMPND 5 SREBP CLEAVAGE ACTIVITY 1,SCA-1; COMPND 6 EC: 3.4.22.56; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: CASPASE-3; COMPND 11 CHAIN: C, D; COMPND 12 SYNONYM: CASP-3,APOPAIN,CYSTEINE PROTEASE CPP32,CPP-32,PROTEIN YAMA, COMPND 13 SREBP CLEAVAGE ACTIVITY 1,SCA-1; COMPND 14 EC: 3.4.22.56; COMPND 15 ENGINEERED: YES; COMPND 16 MOL_ID: 3; COMPND 17 MOLECULE: AC-ASP-GLU-VAL-ASP-CMK; COMPND 18 CHAIN: G, F; COMPND 19 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP3, CPP32; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI K-12; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 83333; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: CASP3, CPP32; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI K-12; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 83333; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 18 ORGANISM_TAXID: 9606 KEYWDS ALLOSTERIC REGULATION; APOPTOSIS; BIOPHYSICS; CASPASE; COMPUTATIONAL KEYWDS 2 BIOLOGY; X-RAY CRYSTALLOGRAPHY; FLUORESCENCE; MOLECULAR DYNAMICS; KEYWDS 3 PROTEIN EVOLUTION, APOPTOSIS, APOPTOSIS-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.E.THOMAS,R.GRINSHPON,P.D.SWARTZ,A.C.CLARK REVDAT 3 25-APR-18 6BG0 1 JRNL REVDAT 2 07-MAR-18 6BG0 1 REMARK REVDAT 1 21-FEB-18 6BG0 0 JRNL AUTH M.E.THOMAS,R.GRINSHPON,P.SWARTZ,A.C.CLARK JRNL TITL MODIFICATIONS TO A COMMON PHOSPHORYLATION NETWORK PROVIDE JRNL TITL 2 INDIVIDUALIZED CONTROL IN CASPASES. JRNL REF J. BIOL. CHEM. V. 293 5447 2018 JRNL REFN ESSN 1083-351X JRNL PMID 29414778 JRNL DOI 10.1074/JBC.RA117.000728 REMARK 2 REMARK 2 RESOLUTION. 2.13 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.12_2829: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.13 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.66 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 32062 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.163 REMARK 3 R VALUE (WORKING SET) : 0.161 REMARK 3 FREE R VALUE : 0.201 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.210 REMARK 3 FREE R VALUE TEST SET COUNT : 1991 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 35.6647 - 5.1166 1.00 2208 146 0.1744 0.1764 REMARK 3 2 5.1166 - 4.0631 1.00 2157 145 0.1170 0.1328 REMARK 3 3 4.0631 - 3.5500 1.00 2166 144 0.1357 0.1719 REMARK 3 4 3.5500 - 3.2257 1.00 2166 141 0.1528 0.1848 REMARK 3 5 3.2257 - 2.9946 1.00 2150 144 0.1609 0.2276 REMARK 3 6 2.9946 - 2.8181 1.00 2152 139 0.1683 0.2092 REMARK 3 7 2.8181 - 2.6770 1.00 2148 147 0.1749 0.2222 REMARK 3 8 2.6770 - 2.5605 1.00 2146 139 0.1705 0.2157 REMARK 3 9 2.5605 - 2.4620 1.00 2143 136 0.1647 0.2444 REMARK 3 10 2.4620 - 2.3770 1.00 2141 156 0.1673 0.2145 REMARK 3 11 2.3770 - 2.3027 1.00 2155 144 0.1804 0.2356 REMARK 3 12 2.3027 - 2.2369 0.99 2150 125 0.2042 0.2888 REMARK 3 13 2.2369 - 2.1780 1.00 2145 155 0.2061 0.2724 REMARK 3 14 2.1780 - 2.1249 0.96 2044 130 0.1975 0.2561 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.210 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.590 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 3978 REMARK 3 ANGLE : 0.853 5358 REMARK 3 CHIRALITY : 0.055 579 REMARK 3 PLANARITY : 0.005 689 REMARK 3 DIHEDRAL : 5.162 3297 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6BG0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-OCT-17. REMARK 100 THE DEPOSITION ID IS D_1000230820. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32061 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.130 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALS WERE OBTAINED AT 18 C BY THE REMARK 280 HANGING DROP VAPOR DIFFUSION METHOD USING 4 ML DROPS THAT REMARK 280 CONTAINED EQUAL VOLUMES OF PROTEIN AND RESERVOIR SOLUTIONS OVER REMARK 280 A 0.5 ML SOLUTION OF 100 MM SODIUM CITRATE, PH 4.9-5.2, 8-18 % REMARK 280 PEG 6000 (W/V), 10 MM DTT, AND 3 MM NAN3. CRYSTALS APPEARED REMARK 280 WITHIN 3-5 DAYS AND WERE BRIEFLY IMMERSED IN A CRYOGENIC REMARK 280 SOLUTION CONTAINING 10% MPD (2-METHYLPENTANE-2,4-DIOL) AND 90% REMARK 280 RESERVOIR SOLUTION., VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 54.43600 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.24950 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 54.43600 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 48.24950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5920 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11010 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -41.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5790 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10750 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE AC-ASP-GLU-VAL-ASP-CMK IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: AC-ASP-GLU-VAL-ASP-CMK REMARK 400 CHAIN: G, F REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 ASN A 3 REMARK 465 THR A 4 REMARK 465 GLU A 5 REMARK 465 ASN A 6 REMARK 465 SER A 7 REMARK 465 VAL A 8 REMARK 465 ALA A 9 REMARK 465 SER A 10 REMARK 465 LYS A 11 REMARK 465 SER A 12 REMARK 465 ILE A 13 REMARK 465 LYS A 14 REMARK 465 ASN A 15 REMARK 465 LEU A 16 REMARK 465 GLU A 17 REMARK 465 PRO A 18 REMARK 465 LYS A 19 REMARK 465 ILE A 20 REMARK 465 ILE A 21 REMARK 465 HIS A 22 REMARK 465 GLY A 23 REMARK 465 SER A 24 REMARK 465 GLU A 25 REMARK 465 SER A 26 REMARK 465 MET A 27 REMARK 465 ALA A 28 REMARK 465 SER A 29 REMARK 465 GLY A 30 REMARK 465 ILE A 31 REMARK 465 SER A 32 REMARK 465 LEU A 33 REMARK 465 ASP A 175 REMARK 465 SER C 176 REMARK 465 GLY C 177 REMARK 465 VAL C 178 REMARK 465 ASP C 179 REMARK 465 ASP C 180 REMARK 465 ASP C 181 REMARK 465 MET C 182 REMARK 465 ALA C 183 REMARK 465 CYS C 184 REMARK 465 MET B 1 REMARK 465 GLU B 2 REMARK 465 ASN B 3 REMARK 465 THR B 4 REMARK 465 GLU B 5 REMARK 465 ASN B 6 REMARK 465 SER B 7 REMARK 465 VAL B 8 REMARK 465 ALA B 9 REMARK 465 SER B 10 REMARK 465 LYS B 11 REMARK 465 SER B 12 REMARK 465 ILE B 13 REMARK 465 LYS B 14 REMARK 465 ASN B 15 REMARK 465 LEU B 16 REMARK 465 GLU B 17 REMARK 465 PRO B 18 REMARK 465 LYS B 19 REMARK 465 ILE B 20 REMARK 465 ILE B 21 REMARK 465 HIS B 22 REMARK 465 GLY B 23 REMARK 465 SER B 24 REMARK 465 GLU B 25 REMARK 465 SER B 26 REMARK 465 MET B 27 REMARK 465 ALA B 28 REMARK 465 SER B 29 REMARK 465 GLY B 30 REMARK 465 ILE B 31 REMARK 465 SER B 32 REMARK 465 LEU B 33 REMARK 465 ASP B 175 REMARK 465 SER D 176 REMARK 465 GLY D 177 REMARK 465 VAL D 178 REMARK 465 ASP D 179 REMARK 465 ASP D 180 REMARK 465 ASP D 181 REMARK 465 MET D 182 REMARK 465 ALA D 183 REMARK 465 CYS D 184 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 34 CG OD1 OD2 REMARK 470 LYS A 57 CD CE NZ REMARK 470 LYS C 224 CD CE NZ REMARK 470 HIS C 277 CG ND1 CD2 CE1 NE2 REMARK 470 ASP B 34 N CB CG OD1 OD2 REMARK 470 LYS B 57 CG CD CE NZ REMARK 470 THR B 59 OG1 CG2 REMARK 470 LYS B 105 CE NZ REMARK 470 LYS B 138 NZ REMARK 470 GLU B 173 CG CD OE1 OE2 REMARK 470 LYS D 210 CD CE NZ REMARK 470 LYS D 224 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS A 163 C1 0QE G 6 0.81 REMARK 500 C ASP G 5 C1 0QE G 6 1.67 REMARK 500 NH2 ARG A 75 O HOH A 401 2.14 REMARK 500 O HOH B 420 O HOH B 423 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 64 71.05 -104.34 REMARK 500 LYS A 82 31.51 76.35 REMARK 500 ALA A 162 149.78 -174.08 REMARK 500 MET B 61 135.54 66.95 REMARK 500 MET B 61 138.72 61.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 301 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLN A 161 OE1 REMARK 620 2 TRP C 206 O 112.9 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA B 301 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLN B 161 OE1 REMARK 620 2 TRP D 206 O 110.9 REMARK 620 N 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NA A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue AZI C 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NA B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue AZI B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue AZI G 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE F 1 and ASP F 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ASP F 5 and 0QE F 6 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE G 1 and ASP G 2 DBREF 6BG0 A 1 175 UNP P42574 CASP3_HUMAN 1 175 DBREF 6BG0 C 176 277 UNP P42574 CASP3_HUMAN 176 277 DBREF 6BG0 B 1 175 UNP P42574 CASP3_HUMAN 1 175 DBREF 6BG0 D 176 277 UNP P42574 CASP3_HUMAN 176 277 DBREF 6BG0 G 1 6 PDB 6BG0 6BG0 1 6 DBREF 6BG0 F 1 6 PDB 6BG0 6BG0 1 6 SEQADV 6BG0 ALA A 9 UNP P42574 ASP 9 ENGINEERED MUTATION SEQADV 6BG0 ALA A 28 UNP P42574 ASP 28 ENGINEERED MUTATION SEQADV 6BG0 ASP A 150 UNP P42574 SER 150 ENGINEERED MUTATION SEQADV 6BG0 ALA B 9 UNP P42574 ASP 9 ENGINEERED MUTATION SEQADV 6BG0 ALA B 28 UNP P42574 ASP 28 ENGINEERED MUTATION SEQADV 6BG0 ASP B 150 UNP P42574 SER 150 ENGINEERED MUTATION SEQRES 1 A 175 MET GLU ASN THR GLU ASN SER VAL ALA SER LYS SER ILE SEQRES 2 A 175 LYS ASN LEU GLU PRO LYS ILE ILE HIS GLY SER GLU SER SEQRES 3 A 175 MET ALA SER GLY ILE SER LEU ASP ASN SER TYR LYS MET SEQRES 4 A 175 ASP TYR PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN SEQRES 5 A 175 LYS ASN PHE HIS LYS SER THR GLY MET THR SER ARG SER SEQRES 6 A 175 GLY THR ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE SEQRES 7 A 175 ARG ASN LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU SEQRES 8 A 175 THR ARG GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER SEQRES 9 A 175 LYS GLU ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL SEQRES 10 A 175 LEU LEU SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR SEQRES 11 A 175 ASN GLY PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE SEQRES 12 A 175 ARG GLY ASP ARG CYS ARG ASP LEU THR GLY LYS PRO LYS SEQRES 13 A 175 LEU PHE ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP SEQRES 14 A 175 CYS GLY ILE GLU THR ASP SEQRES 1 C 102 SER GLY VAL ASP ASP ASP MET ALA CYS HIS LYS ILE PRO SEQRES 2 C 102 VAL GLU ALA ASP PHE LEU TYR ALA TYR SER THR ALA PRO SEQRES 3 C 102 GLY TYR TYR SER TRP ARG ASN SER LYS ASP GLY SER TRP SEQRES 4 C 102 PHE ILE GLN SER LEU CYS ALA MET LEU LYS GLN TYR ALA SEQRES 5 C 102 ASP LYS LEU GLU PHE MET HIS ILE LEU THR ARG VAL ASN SEQRES 6 C 102 ARG LYS VAL ALA THR GLU PHE GLU SER PHE SER PHE ASP SEQRES 7 C 102 ALA THR PHE HIS ALA LYS LYS GLN ILE PRO CYS ILE VAL SEQRES 8 C 102 SER MET LEU THR LYS GLU LEU TYR PHE TYR HIS SEQRES 1 B 175 MET GLU ASN THR GLU ASN SER VAL ALA SER LYS SER ILE SEQRES 2 B 175 LYS ASN LEU GLU PRO LYS ILE ILE HIS GLY SER GLU SER SEQRES 3 B 175 MET ALA SER GLY ILE SER LEU ASP ASN SER TYR LYS MET SEQRES 4 B 175 ASP TYR PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN SEQRES 5 B 175 LYS ASN PHE HIS LYS SER THR GLY MET THR SER ARG SER SEQRES 6 B 175 GLY THR ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE SEQRES 7 B 175 ARG ASN LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU SEQRES 8 B 175 THR ARG GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER SEQRES 9 B 175 LYS GLU ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL SEQRES 10 B 175 LEU LEU SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR SEQRES 11 B 175 ASN GLY PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE SEQRES 12 B 175 ARG GLY ASP ARG CYS ARG ASP LEU THR GLY LYS PRO LYS SEQRES 13 B 175 LEU PHE ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP SEQRES 14 B 175 CYS GLY ILE GLU THR ASP SEQRES 1 D 102 SER GLY VAL ASP ASP ASP MET ALA CYS HIS LYS ILE PRO SEQRES 2 D 102 VAL GLU ALA ASP PHE LEU TYR ALA TYR SER THR ALA PRO SEQRES 3 D 102 GLY TYR TYR SER TRP ARG ASN SER LYS ASP GLY SER TRP SEQRES 4 D 102 PHE ILE GLN SER LEU CYS ALA MET LEU LYS GLN TYR ALA SEQRES 5 D 102 ASP LYS LEU GLU PHE MET HIS ILE LEU THR ARG VAL ASN SEQRES 6 D 102 ARG LYS VAL ALA THR GLU PHE GLU SER PHE SER PHE ASP SEQRES 7 D 102 ALA THR PHE HIS ALA LYS LYS GLN ILE PRO CYS ILE VAL SEQRES 8 D 102 SER MET LEU THR LYS GLU LEU TYR PHE TYR HIS SEQRES 1 G 6 ACE ASP GLU VAL ASP 0QE SEQRES 1 F 6 ACE ASP GLU VAL ASP 0QE HET ACE G 1 3 HET 0QE G 6 1 HET ACE F 1 3 HET 0QE F 6 1 HET NA A 301 1 HET AZI C 301 3 HET NA B 301 1 HET AZI B 302 3 HET AZI G 101 3 HETNAM ACE ACETYL GROUP HETNAM 0QE CHLOROMETHANE HETNAM NA SODIUM ION HETNAM AZI AZIDE ION HETSYN 0QE CHLORO METHYL GROUP FORMUL 5 ACE 2(C2 H4 O) FORMUL 5 0QE 2(C H3 CL) FORMUL 7 NA 2(NA 1+) FORMUL 8 AZI 3(N3 1-) FORMUL 12 HOH *346(H2 O) HELIX 1 AA1 HIS A 56 GLY A 60 5 5 HELIX 2 AA2 GLY A 66 LEU A 81 1 16 HELIX 3 AA3 THR A 92 GLU A 106 1 15 HELIX 4 AA4 LEU A 136 PHE A 142 1 7 HELIX 5 AA5 CYS A 148 THR A 152 5 5 HELIX 6 AA6 TRP C 214 ALA C 227 1 14 HELIX 7 AA7 GLU C 231 PHE C 247 1 17 HELIX 8 AA8 ASP C 253 HIS C 257 5 5 HELIX 9 AA9 HIS B 56 GLY B 60 5 5 HELIX 10 AB1 GLY B 66 LEU B 81 1 16 HELIX 11 AB2 THR B 92 GLU B 106 1 15 HELIX 12 AB3 LEU B 136 ASN B 141 1 6 HELIX 13 AB4 PHE B 142 ARG B 144 5 3 HELIX 14 AB5 CYS B 148 THR B 152 5 5 HELIX 15 AB6 TRP D 214 ALA D 227 1 14 HELIX 16 AB7 GLU D 231 PHE D 247 1 17 HELIX 17 AB8 ASP D 253 HIS D 257 5 5 SHEET 1 AA112 GLU A 84 ASN A 89 0 SHEET 2 AA112 LEU A 46 ASN A 51 1 N ASN A 51 O LYS A 88 SHEET 3 AA112 PHE A 114 LEU A 119 1 O VAL A 117 N ILE A 48 SHEET 4 AA112 LYS A 156 GLN A 161 1 O ILE A 159 N LEU A 118 SHEET 5 AA112 PHE C 193 TYR C 197 1 O LEU C 194 N PHE A 158 SHEET 6 AA112 CYS C 264 SER C 267 -1 O VAL C 266 N TYR C 195 SHEET 7 AA112 CYS D 264 SER D 267 -1 O SER D 267 N ILE C 265 SHEET 8 AA112 PHE D 193 TYR D 197 -1 N TYR D 195 O VAL D 266 SHEET 9 AA112 LYS B 156 GLN B 161 1 N PHE B 158 O LEU D 194 SHEET 10 AA112 ARG B 111 LEU B 119 1 N CYS B 116 O ILE B 159 SHEET 11 AA112 GLU B 43 ASN B 51 1 N ILE B 48 O VAL B 117 SHEET 12 AA112 GLU B 84 ASN B 89 1 O LYS B 88 N ASN B 51 SHEET 1 AA2 3 GLY A 122 GLU A 123 0 SHEET 2 AA2 3 ILE A 126 GLY A 129 -1 O ILE A 126 N GLU A 123 SHEET 3 AA2 3 GLY A 132 ASP A 135 -1 O GLY A 132 N GLY A 129 SHEET 1 AA3 2 ILE A 172 GLU A 173 0 SHEET 2 AA3 2 LYS D 186 ILE D 187 -1 O ILE D 187 N ILE A 172 SHEET 1 AA4 2 LYS C 186 ILE C 187 0 SHEET 2 AA4 2 ILE B 172 GLU B 173 -1 O ILE B 172 N ILE C 187 SHEET 1 AA5 3 GLY C 212 SER C 213 0 SHEET 2 AA5 3 TRP C 206 ASN C 208 -1 N ASN C 208 O GLY C 212 SHEET 3 AA5 3 GLU G 3 VAL G 4 -1 O GLU G 3 N ARG C 207 SHEET 1 AA6 3 GLY B 122 GLU B 123 0 SHEET 2 AA6 3 ILE B 126 GLY B 129 -1 O ILE B 126 N GLU B 123 SHEET 3 AA6 3 GLY B 132 ASP B 135 -1 O GLY B 132 N GLY B 129 SHEET 1 AA7 3 GLY D 212 SER D 213 0 SHEET 2 AA7 3 TRP D 206 ASN D 208 -1 N ASN D 208 O GLY D 212 SHEET 3 AA7 3 GLU F 3 VAL F 4 -1 O GLU F 3 N ARG D 207 LINK OE1 GLN A 161 NA NA A 301 1555 1555 2.83 LINK O TRP C 206 NA NA A 301 1555 1555 2.67 LINK OE1 GLN B 161 NA NA B 301 1555 1555 2.73 LINK O TRP D 206 NA NA B 301 1555 1555 2.75 LINK C ACE G 1 N ASP G 2 1555 1555 1.34 LINK C ACE F 1 N ASP F 2 1555 1555 1.34 LINK C ASP F 5 C1 0QE F 6 1555 1555 1.35 SITE 1 AC1 6 GLN A 161 SER C 205 TRP C 206 TRP C 214 SITE 2 AC1 6 PHE C 215 GLN C 261 SITE 1 AC2 4 TYR A 37 MET A 39 TYR C 276 HOH C 402 SITE 1 AC3 6 GLN B 161 SER D 205 TRP D 206 TRP D 214 SITE 2 AC3 6 PHE D 215 GLN D 261 SITE 1 AC4 6 LYS B 137 THR B 140 ASN B 141 ARG B 144 SITE 2 AC4 6 GLU D 190 PHE D 193 SITE 1 AC5 5 SER A 58 ASP G 2 GLU G 3 VAL G 4 SITE 2 AC5 5 HOH G 203 SITE 1 AC6 10 ARG D 207 ASN D 208 SER D 209 TRP D 214 SITE 2 AC6 10 SER D 249 PHE D 250 HOH D 429 GLU F 3 SITE 3 AC6 10 HOH F 101 HOH F 103 SITE 1 AC7 10 ARG B 64 HIS B 121 GLY B 122 GLN B 161 SITE 2 AC7 10 CYS B 163 TYR D 204 SER D 205 ARG D 207 SITE 3 AC7 10 VAL F 4 HOH F 104 SITE 1 AC8 11 ARG C 207 ASN C 208 SER C 209 TRP C 214 SITE 2 AC8 11 SER C 249 PHE C 250 HOH C 433 GLU G 3 SITE 3 AC8 11 AZI G 101 HOH G 201 HOH G 202 CRYST1 108.872 96.499 68.914 90.00 126.71 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009185 0.000000 0.006849 0.00000 SCALE2 0.000000 0.010363 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018101 0.00000